|
CN101820864A
|
|
Nucleic acid-lipopolymer compositions
|
|
EP1807054A2
|
|
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
|
|
US2004142474A1
|
|
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
|
WO03063827A1
|
|
Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol)
|
|
US2003220274A1
|
|
GLP-1 gene delivery for the treatment of type 2 diabetes
|
|
EP1365716A1
|
|
Biodegradable cationic copolymers of poly(alkylenimine) and poly(ethylene glycol) for the delivery of bioactive agents
|
|
US2003018002A1
|
|
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
|
US6696038B1
|
|
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US6517869B1
|
|
Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
|
|
WO0197781A1
|
|
Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
|
|
BR9912070A
|
|
Poly-l-lysine polyester analog as a soluble, biodegradable gene delivery vehicle
|
|
IL139761D0
|
|
A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
|
|
BR9814273A
|
|
Copolymers grafted as gene carriers
|
|
AU1819499A
|
|
Positively-charged poly{alpha-(omega-aminoalkyl)glycolic acid} for the delivery of a bioactive agent via tissue and cellular uptake
|
